Abionyx Pharma SA
F:609
Abionyx Pharma SA
F:609
Price:
3.315
EUR
-1.92%
Market Closed
Market Cap:
€114.9m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Abionyx Pharma SA
F:609
|
FR |
|
Devyani International Ltd
NSE:DEVYANI
|
IN |
|
Arizona Lithium Ltd
F:UDE0
|
AU |
|
C
|
Coloplast A/S
F:CBHD
|
DK |
|
L
|
Ladder Capital Corp
F:LD1A
|
US |
Wall St Price Targets
Price Targets Summary
Abionyx Pharma SA
Abionyx Pharma SA
Wall Street analysts forecast Abionyx Pharma SA stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for Abionyx Pharma SA is 10.842 EUR with a low forecast of 10.225 EUR and a high forecast of 11.692 EUR.
Lowest Forecast
Price Target
10.225
EUR
208% Upside
Average Forecast
Price Target
10.842
EUR
227% Upside
Highest Forecast
Price Target
11.692
EUR
253% Upside
Abionyx Pharma SA Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is Abionyx Pharma SA's stock price target?
Price Target
10.842
EUR
10.842
EUR
According to Wall Street analysts, the average 1-year price target for Abionyx Pharma SA is 10.842 EUR with a low forecast of 10.225 EUR and a high forecast of 11.692 EUR.
What is the Revenue forecast for Abionyx Pharma SA?
Projected CAGR
112%
112%
The compound annual growth rate for Revenue over the next 3 years is 112%.
